Zdravlje is pleased to announce that as of 1 January 2022, Mr. Semir Attar has joined our senior management team as Director of Regulatory & Public Affairs, directly reporting to Kiren Naidoo (CEO).

Semir brings over 20 years of valuable pharmaceutical industry experience across Regulatory, Public Affairs, Market Access and Commercial functions. Semir joins us from Sanofi (French multinational pharmaceutical company) where he spent the last 10 years, most recently as the Public Affairs & Market Access Country Head for Serbia & Montenegro and the Legal Representative. In addition, Semir has occupied senior positions at various other top-tier multinationals such as Johnson & Johnson, AstraZeneca and Gedeon Richter.

Semir Attar holds a BA in Dental Medicine from the Faculty of Dentistry, University of Belgrade and a MBA from the London School of Commerce, UK. Semir will lead our Regulatory and Public Affairs function across Belgrade and Leskovac.

Commenting on his joining Zdravlje Team, Semir shared his enthusiasm:

“I am very excited to have joined Zdravlje, the company with almost 70-year long tradition in pharmaceuticals, with great heritage and one of the best known brands in the healthcare industry in the region. I am looking forward to taking part in the new chapter of the company’s history.”

“We are very pleased to commence 2022 with such a high-profile addition to our team. We appreciate the deep experience Semir brings and look forward to working with him to realise our ambitious goals.” said Kiren Naidoo, CEO of Zdravlje.

We welcome Semir to the team and wish him all the best in his new role in Zdravlje.